Sabine Jacker executed a binding terms sheet to accquire THCinol/CBDinol CanPharma GmbH from Health House International Limited (ASX:HHI) for Ç1 on November 1, 2022. Under the terms of agreement Sabine Jacker will pay Ç1 forTHCinol/CBDinol CanPharma and will also acquire liabilities of up to Ç2.7 million consisting of: a) trade creditors - Ç990,000 b) short term debt - multiple private lenders - Ç1,110,000 maturing July 1, 2023 c) long term debt - Investitionsbank des Landes Brandenburg (ILB) - Ç600,000 maturing September 31, 2026. The transaction is expected to close by December 31, 2022 and is subject to third-party approvals, regulatory consents or conditions required to give effect to the transactions contemplated by the Terms Sheet being obtained, ILB releasing Health House from its guarantee under the ILB Obligation, Neither Health House nor Sabine Jackson being in material breach of the terms of the Terms Sheet providing no party can rely on its own breach to prevent completion.